182 related articles for article (PubMed ID: 8948804)
1. [Adrenocortical carcinoma. Current approaches in diagnosis and treatment].
Sapienza P; Tedesco M; Burchi C; Battistini M; Cavallaro A
Ann Ital Chir; 1995; 66(5):651-63. PubMed ID: 8948804
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical carcinoma: retrospective study of 14 patients experienced at a single institution over 34 years.
Nishida S; Itoh N; Sasao T; Masumori N; Taguchi K; Tsukamoto T
Int J Urol; 2007 Jul; 14(7):581-4. PubMed ID: 17645596
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical carcinoma: epidemiology and natural history.
Boscaro M; Fallo F; Barzon L; Daniele O; Sonino N
Minerva Endocrinol; 1995 Mar; 20(1):89-94. PubMed ID: 7651287
[TBL] [Abstract][Full Text] [Related]
4. The impact of tumor stage on prognosis in children with adrenocortical carcinoma.
Tucci S; Martins AC; Suaid HJ; Cologna AJ; Reis RB
J Urol; 2005 Dec; 174(6):2338-42, discussion 2342. PubMed ID: 16280838
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical carcinoma: clinical and laboratory observations.
Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
[TBL] [Abstract][Full Text] [Related]
6. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcome of stage III and IV adrenocortical carcinoma.
Ohwada S; Izumi M; Kawate S; Hamada K; Toya H; Togo N; Horiguchi J; Koibuchi Y; Takahashi T; Yamada M
Jpn J Clin Oncol; 2007 Feb; 37(2):108-13. PubMed ID: 17277000
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.
Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C
Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179
[TBL] [Abstract][Full Text] [Related]
10. A twelve-year experience with adrenal cortical carcinoma in a single institution: long-term survival after surgical treatment and transcatheter arterial embolization.
Soga H; Takenaka A; Ooba T; Nakano Y; Miyake H; Takeda M; Tanaka K; Hara I; Fujisawa M
Urol Int; 2009; 82(2):222-6. PubMed ID: 19322014
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
[TBL] [Abstract][Full Text] [Related]
12. Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up.
Schwarte S; Brabant EG; Bastian L; Bruns F
Anticancer Res; 2007; 27(4A):1917-20. PubMed ID: 17649795
[TBL] [Abstract][Full Text] [Related]
13. Experience with the surgical treatment of adrenal cortical carcinoma.
Meyer A; Niemann U; Behrend M
Eur J Surg Oncol; 2004 May; 30(4):444-9. PubMed ID: 15063900
[TBL] [Abstract][Full Text] [Related]
14. Outcome of adrenocortical tumors in children.
Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.
Luton JP; Cerdas S; Billaud L; Thomas G; Guilhaume B; Bertagna X; Laudat MH; Louvel A; Chapuis Y; Blondeau P
N Engl J Med; 1990 Apr; 322(17):1195-201. PubMed ID: 2325710
[TBL] [Abstract][Full Text] [Related]
16. [Recent advances in the treatment of adrenocortical carcinomas].
Ducry J; Berthold D; Pralong F
Rev Med Suisse; 2012 Nov; 8(362):2181-4, 2186. PubMed ID: 23240320
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathologic profile of adrenocortical tumors.
Upadhye PS; Desai MP; Colaco MP; Desai PB; Deshpande RK; Mokal RA
Indian Pediatr; 1997 Jun; 34(6):481-90. PubMed ID: 9357203
[TBL] [Abstract][Full Text] [Related]
19. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
20. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
